ABT
54
-2
NVDA
56
2
OXY
50
-2
KMB
44
2
WHR
35
3
DD
48
2
UNH
46
4
PFG
45
2
AAP
35
6
NRG
72
-5
OMC
65
-3
VFC
13
2
DG
32
2
EXPE
50
-12
CHRW
39
3
BLK
49
5
AEE
41
4
HRL
36
-2
BAX
47
2
EFX
54
-11
ABT
54
-2
NVDA
56
2
OXY
50
-2
KMB
44
2
WHR
35
3
DD
48
2
UNH
46
4
PFG
45
2
AAP
35
6
NRG
72
-5
OMC
65
-3
VFC
13
2
DG
32
2
EXPE
50
-12
CHRW
39
3
BLK
49
5
AEE
41
4
HRL
36
-2
BAX
47
2
EFX
54
-11
Financhill
Back

Syndax Pharmaceuticals 10K Form

Buy
55

SNDX
Syndax Pharmaceuticals

Last Price:
20.81
Seasonality Move:
8.12%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-02 10Q SNDX/Syndax Pharmaceuticals Quarterly
2023-08-03 10Q SNDX/Syndax Pharmaceuticals Quarterly
2023-05-08 10Q SNDX/Syndax Pharmaceuticals Quarterly
2022-11-03 10Q SNDX/Syndax Pharmaceuticals Quarterly
2022-08-08 10Q SNDX/Syndax Pharmaceuticals Quarterly
2022-05-09 10Q SNDX/Syndax Pharmaceuticals Quarterly

Receive SNDX News And Ratings

See the #1 stock for the next 7 days that we like better than SNDX

SNDX Financial Statistics

Sales & Book Value

Annual Sales: $139.71M
Cash Flow: $-41.35M
Price / Cash Flow: 0
Annual Sales: $6.53
Price / Book: 3.13

Profitability

EPS (TTM): -2.96000
Net Income (TTM): $-209.36M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Syndax Pharmaceuticals Earnings Forecast

Key Syndax Pharmaceuticals Financial Ratios

  • The Selling, General & Administrative Expenses for SNDX have been equal to 18.07% of Gross Profit Margin.
  • The Interest Expense is -0.10% of Operating Income.
  • Per Share Earnings over the last 12 years have been positive in 5 years.

Syndax Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SNDX
CUSIP: 87164F
Website: syndax.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SNDX Technical Analysis vs Fundamental Analysis

Buy
55
Syndax Pharmaceuticals (SNDX) is a Buy

Is Syndax Pharmaceuticals a Buy or a Sell?